thalidomide has been researched along with Mandibular Neoplasms in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Mandibular Neoplasms: Tumors or cancer of the MANDIBLE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient was diagnosed with multiple myeloma and received chemotherapy with thalidomide, cyclophosphamide and dexamethasone." | 1.39 | Multiple myeloma presenting as plasmacytoma of the jaws showing prominent bone formation during chemotherapy. ( An, CH; An, SY; Choi, KS; Heo, MS, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, SY | 1 |
| An, CH | 1 |
| Choi, KS | 1 |
| Heo, MS | 1 |
| Tai, YT | 1 |
| Yen, PC | 1 |
| Chen, HH | 1 |
| Chou, EK | 1 |
| Ribas, C | 1 |
| Colleoni, G | 1 |
| Almeida, M | 1 |
| Duch, CR | 1 |
| Ohashi, C | 1 |
| Segreto, R | 1 |
| Silva, MR | 1 |
3 other studies available for thalidomide and Mandibular Neoplasms
| Article | Year |
|---|---|
Multiple myeloma presenting as plasmacytoma of the jaws showing prominent bone formation during chemotherapy.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; A | 2013 |
Thalidomide-related vessel thrombosis in microsurgical free tissue transfer.
Topics: Angiogenesis Inhibitors; Humans; Lymph Node Excision; Male; Mandibular Neoplasms; Microsurgery; Midd | 2010 |
Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma.
Topics: Angiogenesis Inhibitors; Humans; Male; Mandibular Neoplasms; Middle Aged; Multiple Myeloma; Plasmacy | 2004 |